Status:

COMPLETED

Time Restricted Eating for Metabolic and Psychological Optimization

Lead Sponsor:

University of North Carolina, Chapel Hill

Collaborating Sponsors:

Duke University

National Institute on Aging (NIA)

Conditions:

Mild Cognitive Impairment

Obesity

Eligibility:

All Genders

65-80 years

Phase:

NA

Brief Summary

Obesity and related metabolic comorbidities have been associated with more than a 4-fold increased risk of incident cognitive impairment, including Alzheimer's disease and related dementias (ADRD). Dy...

Detailed Description

Obese older adults with mild cognitive impairment with mild cognitive impairment will be asked to participate in a 12 week time restricted fasting intervention. Working with a behavioral psychologist,...

Eligibility Criteria

Inclusion

  • Subjects will include those men and women:
  • aged 65-80 years,
  • with amnestic Mild Cognitive Impairment (Montreal Cognitive Assessment Battery score \[MoCA\] total score 19-25; and score of \> 1.0 on the Mail-in Cognitive Function Screening Instrument),
  • obese (body mass index 30-40 kg/m\^2),
  • sedentary, and
  • willing to participate in all aspects of the proposed intervention.

Exclusion

  • Reasons for participant exclusion will include:
  • secondary causes of obesity,
  • evidence of clinical dementia (MoCA score \< 18), severe chronic kidney disease (eGFR \<45 ml/min/1.73m\^2),
  • heart failure,
  • high grade arrhythmias,
  • severe valvular heart disease,
  • severe asthma or chronic obstructive lung disease,
  • diabetes requiring insulin,
  • musculoskeletal or neurologic problems that would preclude participation in aerobic exercise training,
  • a major psychiatric disorder,
  • a history of drug abuse,
  • alcohol consumption \>14 drinks/week,
  • gastric bypass surgery,
  • non-English speaking, or
  • a life-limiting comorbid medical condition (e.g. cancer).

Key Trial Info

Start Date :

August 7 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 26 2025

Estimated Enrollment :

33 Patients enrolled

Trial Details

Trial ID

NCT05997316

Start Date

August 7 2023

End Date

June 26 2025

Last Update

September 4 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of North Carolina

Chapel Hill, North Carolina, United States, 27519